logo
Select company
Select metric
$ -13.56MConsolidated Income
VS
Market
32
Sector
62
Industry
34
History
74
$ 2.29Close
$ 1 - $ 2.65 52-Week Range
Ticker Information

Ticker

AYTU

Company Name

AYTU BIOPHARMA INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

AYTU BIOPHARMA INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AYTU - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -13.56M
3/31/2025$ 1.64M
12/31/2024$ -5.24M
9/30/2024$ -6.25M
6/30/2024$ -15.84M
3/31/2024$ -13.68M
12/31/2023$ -18M
9/30/2023$ -24.47M
6/30/2023$ -17.05M
3/31/2023$ -32.3M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AYTU BIOPHARMA INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -13M.
  • Over the past 5 years, AYTU BIOPHARMA INC's average Cons. Inc. has been $ -41.57M.
  • The median Cons. Inc. for AYTU BIOPHARMA INC during this period was $ -23.39M
  • AYTU BIOPHARMA INC reached its highest Cons. Inc. over the past 5 years at $ 1.64M.
  • The lowest Cons. Inc. recorded by AYTU BIOPHARMA INC in the same timeframe $ -111.47M

AYTU BIOPHARMA INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
FLGC : FLORA GROWTH CORP $ -13.05MRMTI : ROCKWELL MEDICAL INC $ -2.1MADAP : ADAPTIMMUNE THERAPEUTICS PLC $ -169.76MCOSM : COSMOS HEALTH INC $ -15.37MIRIX : IRIDEX CORP $ -5.45MIMCC : IM CANNABIS CORP $ -1.69MBFRI : BIOFRONTERA INC $ -16.59MAPUS : APIMEDS PHARMACEUTICALS US INC $ -3.71MHBIO : HARVARD BIOSCIENCE INC $ -57.41MRVP : RETRACTABLE TECHNOLOGIES INC $ -8.74M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

AYTU - Consolidated Income, Last 5 years

$ -111.47M

Minimum

Mar 31, 2022

$ 1.64M

Maximum

Mar 31, 2025

$ -41.57M

Average

$ -23.39M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M